150 related articles for article (PubMed ID: 37302632)
1. pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Mahami S; Salehi M; Mehrabi M; Vahedi H; Hassani MS; Bitaraf FS; Omri A
Int J Biol Macromol; 2023 Jul; 244():125332. PubMed ID: 37302632
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat.
Mahboubi Kancha M; Alizadeh M; Mehrabi M
BMC Complement Med Ther; 2024 Jan; 24(1):39. PubMed ID: 38225618
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
[TBL] [Abstract][Full Text] [Related]
4. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
[TBL] [Abstract][Full Text] [Related]
5. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
[TBL] [Abstract][Full Text] [Related]
6. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effect of ursodeoxycholic acid-berberine supramolecular nanoparticles on ulcerative colitis based on supramolecular system induced by weak bond].
Gao S; Gao F; Kong JW; Wang ZJ; Zheng HC; Jiang XQ; Xu SJ; Li SL; Lu MJ; Dai ZQ; Chu FH; Xu B; Lei HM
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2739-2748. PubMed ID: 37282934
[TBL] [Abstract][Full Text] [Related]
8. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
9. Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.
Li YH; Zhang M; Xiao HT; Fu HB; Ho A; Lin CY; Huang Y; Lin G; Bian ZX
PLoS One; 2015; 10(12):e0144101. PubMed ID: 26642326
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
11. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
[TBL] [Abstract][Full Text] [Related]
13. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
15. Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
Xu W; Su W; Xue Z; Pu F; Xie Z; Jin K; Polyakov NE; Dushkin AV; Su W
Pharm Res; 2021 Apr; 38(4):693-706. PubMed ID: 33754258
[TBL] [Abstract][Full Text] [Related]
16. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
[TBL] [Abstract][Full Text] [Related]
18. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice.
Bai XY; Yan Y; Wang L; Zhao LG; Wang K
Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641
[TBL] [Abstract][Full Text] [Related]
19. Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model.
Chang C; Liu H; Li X; Song D; Liu Y; Lu C; Zhen Y; Chen Y; Xu J; Li W; Jia X; Chen Z; Chen R
Int J Nanomedicine; 2024; 19():1205-1224. PubMed ID: 38348171
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]